Evofem Biosciences Inc
EVFM
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.06M
Close$
Share Statistics
| Market cap | $1.06 Million |
|---|---|
| Enterprise Value | $69.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | -1.32 |
| Outstanding Shares | 133,246,864 |
Return
| Return on Equity | 18.96% |
|---|---|
| Return on Assets | -207.90% |
| Return on Invested Capital | 3.43% |
Valuation & Multiples
| P/E Ratio | -0.16 |
|---|---|
| PEG | -0.03 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 7.25 |
| Enterprise Value to EBIT | -24.87 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | -0.83 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 15, 2026
EPS Estimate
$-914.06
Average shareholder expectationRevenue Estimate
$1.69 M
Average shareholder expectationNext Earnings Call
Expected Date
August 19, 2026
EPS Estimate
$-660.94
Average shareholder expectationRevenue Estimate
$2.68 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Evofem Biosciences Inc
CEO: Saundra Pelletier